Literature DB >> 23562658

Silencing of the P2X(7) receptor enhances amyloid-β phagocytosis by microglia.

Jiong Ni1, Peijun Wang, Jingfa Zhang, Wei Chen, Limin Gu.   

Abstract

P2X7 receptor (P2X7R) is an ATP-gated cation channel that promotes microglia activation and plays a critical role in the pathogenesis of Alzheimer's disease. Inhibiting P2X7R indirectly reduces the rate of amyloid-β (Aβ)-induced neurodegeneration by suppressing secretion of inflammatory factors from activated microglia. We used RNA interference to silence P2X7R in microglial cells in vitro and found it markedly increased microglial phagocytosis of Aβ1-42. Increased phagocytic activity was dependent on decreasing the rate of interleukin-1β release from microglia and required inhibition of the COX-2 pathway. Modulation of microglial phagocytosis and secretion via silencing P2X7R may be a promising therapeutic option for the treatment of Alzheimer's disease.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23562658     DOI: 10.1016/j.bbrc.2013.03.079

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

Review 1.  Central nervous system myeloid cells as drug targets: current status and translational challenges.

Authors:  Knut Biber; Thomas Möller; Erik Boddeke; Marco Prinz
Journal:  Nat Rev Drug Discov       Date:  2015-12-04       Impact factor: 84.694

Review 2.  Advances in Drug Discovery and Development in Geriatric Psychiatry.

Authors:  Alexander C Conley; Paul A Newhouse
Journal:  Curr Psychiatry Rep       Date:  2018-03-05       Impact factor: 5.285

Review 3.  A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity?

Authors:  Stefania Merighi; Manuela Nigro; Alessia Travagli; Silvia Pasquini; Pier Andrea Borea; Katia Varani; Fabrizio Vincenzi; Stefania Gessi
Journal:  Int J Mol Sci       Date:  2022-05-02       Impact factor: 6.208

4.  Cobalt Protoporphyrin Upregulates Cyclooxygenase-2 Expression Through a Heme Oxygenase-Independent Mechanism.

Authors:  Hsiao-Yun Lin; Chon-Haw Tsai; Chingju Lin; Wei-Lan Yeh; Cheng-Fang Tsai; Pei-Chun Chang; Ling-Hsuan Wu; Dah-Yuu Lu
Journal:  Mol Neurobiol       Date:  2015-08-09       Impact factor: 5.590

5.  Brain region-specific gene expression profiles in freshly isolated rat microglia.

Authors:  Karlijn J Doorn; John J P Brevé; Benjamin Drukarch; Hendrikus W Boddeke; Inge Huitinga; Paul J Lucassen; Anne-Marie van Dam
Journal:  Front Cell Neurosci       Date:  2015-03-12       Impact factor: 5.505

6.  Possible protective role of the 489C>T P2X7R polymorphism in Alzheimer's disease.

Authors:  Juana M Sanz; Simonetta Falzoni; Roberta Rizzo; Francesco Cipollone; Giovanni Zuliani; Francesco Di Virgilio
Journal:  Exp Gerontol       Date:  2014-10-16       Impact factor: 4.032

Review 7.  The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets.

Authors:  Santa Mammana; Paolo Fagone; Eugenio Cavalli; Maria Sofia Basile; Maria Cristina Petralia; Ferdinando Nicoletti; Placido Bramanti; Emanuela Mazzon
Journal:  Int J Mol Sci       Date:  2018-03-13       Impact factor: 5.923

Review 8.  The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?

Authors:  Luiz E B Savio; Paola de Andrade Mello; Cleide Gonçalves da Silva; Robson Coutinho-Silva
Journal:  Front Pharmacol       Date:  2018-02-06       Impact factor: 5.810

Review 9.  The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brain.

Authors:  Bernd L Fiebich; Shamima Akter; Ravi Shankar Akundi
Journal:  Front Cell Neurosci       Date:  2014-09-01       Impact factor: 5.505

10.  The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer's disease.

Authors:  Marina Saresella; Francesca La Rosa; Federica Piancone; Martina Zoppis; Ivana Marventano; Elena Calabrese; Veronica Rainone; Raffaello Nemni; Roberta Mancuso; Mario Clerici
Journal:  Mol Neurodegener       Date:  2016-03-03       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.